Premium
Short‐pulse duration retinal lasers: a review
Author(s) -
Chehade Luke,
Chidlow Glyn,
Wood John,
Casson Robert J
Publication year - 2016
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/ceo.12754
Subject(s) - medicine , retinal , retinal pigment epithelium , ophthalmology , laser , retina , drusen , laser coagulation , optometry , optics , visual acuity , physics
The development of lasers for biological use was an important medical advance in the 20th century with numerous evidence‐based therapeutic applications to retinal disease, including capillary leakage at the macula. Although the role of photocoagulative laser in the treatment of macular oedema has diminished, there is evidence for a modified role in clinical management, particularly for extrafoveal leakage. Additionally, it may reduce the frequency of required intravitreal injections and assist in visual stabilization when used as an adjunct. The tissue destructive effect of photocoagulative lasers has motivated the development of safer macular lasers and the search for novel therapeutic applications, including treatment of drusen and regeneration of dysfunctional retinal pigment epithelium.